Impedimed Limited Financial Overview
Impedimed Limited's market cap is currently $47.27M. The company's EPS TTM is $; its P/E ratio is -2.97; Impedimed Limited is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.